U.S. Stocks Finish Higher After Promising Vaccine Study
The Dow industrials and S&P 500 rose as investors cheered promising results from the study of an experimental coronavirus vaccine and Goldman Sachs ...Continue reading on Wall Street Journal
More articles about Vaccine
Wall Street climbs, tentatively, with hopes for vaccine
New York – Wall Street is rising on Wednesday with hopes for a COVID-19 vaccine. Investors see a vaccine as the best way for the economy and human life to ...Continue reading
U.S. Stocks Climb After Promising Vaccine Study
The Dow industrials and S&P 500 rose as investors cheered promising results from the study of an experimental coronavirus vaccine and Goldman Sachs ...Continue reading
Moderna's coronavirus vaccine ready to advance to final phase of ...
Nearly two dozen possible COVID-19 vaccines are in various stages of testing around the world. Candidates from China and Britain's Oxford University also are ...Continue reading
Moderna has started turning out COVID-19 vaccine doses for quick ...
Moderna and its partners in the federal government are just now gearing up for a late-stage COVID-19 vaccine trial set to launch later this month, but at the same ...Continue reading
Moderna stock surges after company announces promising ...
The biotech company said its potential coronavirus vaccine generated a promising immune response in an early-stage human trial.Continue reading
Boeing Stock Is Soaring on Hope for a Vaccine
The best thing for commercial aerospace these days would be an effective vaccine against Covid-19. Moderna is closer to delivering just that.Continue reading
As scientists race toward a coronavirus vaccine, some worry that key ...
In retrospect, "Operation Warp Speed" was probably not the best name for the United States' COVID-19 vaccine research and development efforts. At least that's ...Continue reading
COVID-19 vaccine: Early Oxford trial data to be published next week
COVID-19 vaccine: Oxford University and AstraZeneca will publish early results from human trials next week in the journal Lancet.Continue reading
Moderna Vaccine Looks Safe, May Need Two Doses. Now To Test It ...
Researchers still aren't sure if the vaccine will work based on the new evidence, but the results from the phase 1 clinical trial suggest the vaccine is safe and is ...Continue reading
Moderna's COVID-19 vaccine candidate appears to be safe and ...
It's too early to say whether the vaccine candidate can protect someone from the coronavirus that causes COVID-19, but early trials are encouraging.Continue reading